Total Payments
$7,115
2024 Payments
$1,403
Companies
13
Transactions
187
Payment Breakdown by Category
Food & Beverage$7,115 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,115 | 187 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,102 | 43 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,951 | 38 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $784.91 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $703.91 | 37 | $0 (2024) |
| PFIZER INC. | $636.80 | 28 | $0 (2024) |
| Amgen Inc. | $225.41 | 11 | $0 (2024) |
| Dexcom, Inc. | $169.91 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $159.60 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $126.79 | 6 | $0 (2024) |
| Lilly USA, LLC | $106.65 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,403 | 34 | AstraZeneca Pharmaceuticals LP ($665.96) |
| 2023 | $1,649 | 43 | AstraZeneca Pharmaceuticals LP ($521.43) |
| 2022 | $1,671 | 55 | Novo Nordisk Inc ($635.19) |
| 2021 | $2,392 | 55 | Novo Nordisk Inc ($827.67) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.16 | General |
| Category: Cardiovascular | ||||||
| 11/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.37 | General |
| Category: Cardiovascular | ||||||
| 09/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $114.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiology | ||||||
| 06/28/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $117.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $113.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiology | ||||||
| 05/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/08/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $1.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: DIABETES | ||||||
| 04/05/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: Structural Heart | ||||||
About Maria Obrycka, NP
Maria Obrycka, NP is a Adult Health healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2014. The National Provider Identifier (NPI) number assigned to this provider is 1033514013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Maria Obrycka, NP has received a total of $7,115 in payments from pharmaceutical and medical device companies, with $1,403 received in 2024. These payments were reported across 187 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($7,115).
Ad
Practice Information
- Specialty Adult Health
- Location New York, NY
- Active Since 11/03/2014
- Last Updated 01/30/2019
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1033514013
Products in Payments
- Ozempic (Drug) $1,313
- LOKELMA (Drug) $856.89
- FARXIGA (Drug) $827.24
- XARELTO (Drug) $784.91
- ENTRESTO (Drug) $678.29
- ELIQUIS (Drug) $634.14
- Rybelsus (Drug) $269.78
- BRILINTA (Drug) $266.53
- Repatha (Biological) $225.41
- DEXCOM G7 GSS (161) (Medical Supply) $169.91
- JARDIANCE (Drug) $159.60
- RYBELSUS (Drug) $151.60
- Wegovy (Drug) $122.09
- MOUNJARO (Drug) $106.65
- VYNDAQEL (Drug) $81.92
- AMPLATZER AMULET (Device) $57.58
- MITRACLIP (Device) $47.88
- CAMZYOS (Drug) $47.53
- LEQVIO (Drug) $25.62
- VERQUVO (Drug) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in New York
Ms. Donna Catamero, Np, NP
Adult Health — Payments: $173,379
Adult Health $173,379
Mrs. Juliet Escalon, Anp, ANP
Adult Health — Payments: $45,931
Adult Health $45,931
Alyson Harty, Np, NP
Adult Health — Payments: $41,841
Adult Health $41,841
Teshmanie Rampersaud, Np, NP
Adult Health — Payments: $22,782
Adult Health $22,782
Mrs. Monica Richey, Np, NP
Adult Health — Payments: $17,240
Adult Health $17,240
Damaris Carriero, Np, NP
Adult Health — Payments: $15,518
Adult Health $15,518